Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Use this RIGL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RIGL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RIGL SEC filings page. Lician reads the product cache first so this HTML stays unique to Rigel Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RIGL income, balance, and cash tables.